Compare JFIN & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JFIN | INFU |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.5M | 208.8M |
| IPO Year | 2018 | 2005 |
| Metric | JFIN | INFU |
|---|---|---|
| Price | $4.05 | $9.14 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 75.3K | ★ 168.6K |
| Earning Date | 06-03-2026 | 05-07-2026 |
| Dividend Yield | ★ 17.47% | N/A |
| EPS Growth | N/A | ★ 181.82 |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $143,436,000.00 |
| Revenue This Year | N/A | $3.20 |
| Revenue Next Year | N/A | $7.31 |
| P/E Ratio | ★ $1.35 | $181.00 |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $3.70 | $5.43 |
| 52 Week High | $18.70 | $11.04 |
| Indicator | JFIN | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 42.97 | 48.46 |
| Support Level | $3.80 | $8.49 |
| Resistance Level | $4.54 | $9.97 |
| Average True Range (ATR) | 0.23 | 0.39 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 36.98 | 27.40 |
Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.